Motus Therapeutics
AcquiredBoston, United States · Founded 2008 · $25.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2008
- Business Model
- B2B
- Total Funding
- $25.0M
- Last Round
- $25.0M Series BJan 2012
- Rounds
- 2
- Acquisition Date
- Oct 2016
About
Motus Therapeutics was a Boston-based biotechnology company developing peptide therapeutics for gastrointestinal diseases. Its lead program was relamorelin, a ghrelin agonist for diabetic gastroparesis. Allergan acquired Motus Therapeutics for $200 million upfront in December 2016.
Summary
Motus Therapeutics is a Biotech company based in Boston, United States, founded in 2008. It has raised $25.0M in total across 2 rounds, most recently a $25.0M Series B round in Jan 2012. Investors include New Enterprise Associates and Allergan.
Funding History
Oct 2016
Sign up to see all 3 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/motus-therapeutics"><img src="https://indexed.vc/api/badge/company/motus-therapeutics" alt="Motus Therapeutics on Indexed.vc" width="260" height="76" /></a>